Medipharm Labs Corp T.LABS

Then consider the comments here towards management

[piduks]

as a sample of the greater poplulation of retail investors that have seen a stock price languishing for the last 2 years under current management while the Vivo acuisition did 2 things.   It diluted the exisiting shareholders and DELAYED Medipharm Labs from achieving profitability no matter how senior management "paints" their so called savings with the two companies coming together including a MISS on earnings profitability in Q1 of 2024.   Senior management needs to get voted out.

[CADInvestor12]

You are spewing absolute garbage, and have no idea what you're talking about. Medipharm and VIVOs COMBINED OPEX is 10% lower than when Medipharm operated standalone. In your mind, reduced input costs from vertically integrating, improved plant utilization, new revenue streams (international & direct to patient) delayed profitability? Take a look at their margin improvements QoQ post